Previous close | 11.00 |
Open | 11.00 |
Bid | 9.50 |
Ask | 14.00 |
Strike | 35.00 |
Expiry date | 2024-01-19 |
Day's range | 11.00 - 11.00 |
Contract range | N/A |
Volume | |
Open interest | 65 |
U.S. officials met again with RSV vaccine manufacturers this week amid ongoing efforts to boost access to the shots, the White House said in a statement on Thursday after senior Biden administration officials met with the companies last week. The officials on Tuesday met with representatives of Sanofi SA, AstraZeneca and Thermo Fisher "and urged them to work expeditiously to meet demand for immunizations this winter season through the commercial market," the White House said in a statement.
Paul Hudson needs to convince investors that pharma group’s new blockbuster drugs will be successful
European shares paused on Thursday afters recent strong gains, while data in Germany added to worries that the industrial sector will continue to drag on euro zone's largest economy. The pan-European STOXX 600 slipped 0.3% after touching a more than four-month high on Wednesday, while Germany's DAX dipped 0.2% after scaling a fresh all-time high in the prior session.